The landscape of dementia prognosis has evolved radically with the advent of complex biomarkers, such as amyloid PET scans, tau imaging, and blood-primarily based assessments that may detect Alzheimer's pathology several years prior to signs or symptoms emerge. When these technological advancements characterize exceptional development in comprehend